Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High Soluble Amyloid-β42 Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer's Disease-Causing Mutations.

Journal of Alzheimer's disease : JAD - 1 Jan 2022

Sturchio Andrea, Dwivedi Alok K, Malm Tarja, Wood Matthew J A, Cilia Roberto, Sharma Jennifer S, Hill Emily J, Schneider Lon S, Graff-Radford Neill R, Mori Hiroshi, Nübling Georg, El Andaloussi Samir, Svenningsson Per, Ezzat Kariem, Espay Alberto J

Abstract excerpt

BACKGROUND: In amyloid-positive individuals at risk for Alzheimer's disease (AD), high soluble 42-amino acid amyloid-β (Aβ42) levels are associated with normal cognition. It is unknown if this relationship applies longitudinally in a genetic cohort. OBJECTIVE: To test the hypothesis that high Aβ42 preserves normal cognition in amyloid-positive individuals with Alzheimer's disease (AD)-causing mutations (APP,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloid beta-Peptides
Share to Amyloidosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cognition

Share to Cognitive Dysfunction

Share to Dementia

Share to Peptide Fragments

Share to Positron-Emission Tomography

Share to tau Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 36120786
DOI: 10.3233/JAD-220808
PMCID: PMC9661329

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High Soluble Amyloid-β42 Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer's Disease-Causing Mutations.PMID 36120786Read ↗

Predicting Progression & Cognitive Decline in Amyloid-Positive Patients with Alzheimer's DiseaseSemantic proximity Read ↗

Progression from MCI to AD: predictive value of CSF Aβ42 is modified by APOE genotype.Semantic proximity Read ↗

Polygenic effect on accelerated tau pathology accumulation in Alzheimer’s disease: implications for patient selection in clinical trialsSemantic proximity Read ↗

Genetic drivers of progression in Alzheimer's disease are distinct from disease risk.Semantic proximity Read ↗

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.Semantic proximity Read ↗

Amyloid PET predicts atrophy in older adults without dementia: Results from the AMYPAD Prognostic & Natural History StudySemantic proximity Read ↗

Plasma biomarkers predict amyloid conversion and cognitive decline in cognitively unimpaired adultsSemantic proximity Read ↗

Effects of APOE ε4 and amyloid pathology on longitudinal tau biomarkers, neurodegeneration, and cognitive decline in mild cognitive impairment.Semantic proximity Read ↗

An improved model for disease progression in patients from the Alzheimer's disease neuroimaging initiative.Semantic proximity Read ↗

Don't forget about tau: the effects of ApoE4 genotype on Alzheimer's disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment-data from the Dementia Competence Network.Semantic proximity Read ↗

Quantifying natural amyloid plaque accumulation in the continuum of Alzheimer’s disease using ADNISemantic proximity Read ↗

Brain Amyloid Deposition and Longitudinal Cognitive Decline in Nondemented Older Subjects: Results from a Multi-Ethnic Population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.